[11C]-methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl)-methyl]-1- piperazinecarboxylate ([11C]GR89696): synthesis and in vivo binding to kappa opiate receptors.

GR89696, racemic methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl) methyl]-1-piperazinecarboxylate, a kappa opioid receptor ligand, was labeled with [11C]methyl chloroformate. The radiochemical yield was 20% with an observed specific radioactivity of 75.5 GBq/micromol at end of synthesis (2,040 mCi/micromol). Five minutes after intravenous administration, 5.4% of the injected dose accumulated in mouse whole brain. Brain region to cerebellar ratios increased over time with ratios at 90 min of 7.8, 5.6, and 4.5 for the hypothalamus, olfactory tubercle, and striatum, respectively. The uptake of [11C]GR89696 correlated with known kappa opioid receptor densities and was inhibited by kappa opioid selective drugs.

[1]  R. Dannals,et al.  Synthesis of N1'-([18F]fluoroethyl)naltrindole ([18F]FEtNTI): A radioligand for positron emission tomographic studies of delta opioid receptors , 1999 .

[2]  R. Lahti,et al.  U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist. , 1983, The Journal of pharmacology and experimental therapeutics.

[3]  A. Lipkowski,et al.  Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. , 1987, Life sciences.

[4]  R. Zukin,et al.  Neuroanatomical localization ofκ 1and κ 2 opioid receptors in rat and guinea pig brain , 1991, Brain Research.

[5]  M. Ticku,et al.  Central cardiovascular effects of baclofen in spontaneously hypertensive rats. , 1987, Life sciences.

[6]  T. Cicero,et al.  Autoradiography of [3H]U-69593 binding sites in rat brain: evidence for κ opioid receptor subtypes , 1988 .

[7]  M. Iadarola,et al.  GR89,696 is a kappa-2 opioid receptor agonist and a kappa-1 opioid receptor antagonist in the guinea pig hippocampus. , 1997, The Journal of pharmacology and experimental therapeutics.

[8]  A. Tavani,et al.  Interaction of U-69,593 with μ-, ∂- and k-opioid binding sites and its analgesic and intestinal effects in rats , 1988 .

[9]  J. Prous,et al.  U-50,488 , 1982 .

[10]  Alan A. Wilson,et al.  Synthesis of carbon-11 labeled diprenorphine: A radioligand for positron emission tomographic studies of opiate receptors , 1987 .

[11]  R. Dubner,et al.  Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation. , 1997, The Journal of pharmacology and experimental therapeutics.

[12]  N. Hayward,et al.  Neuroprotective actions of GR89696, a highly potent and selective κ‐opioid receptor agonist , 1991 .

[13]  M. Welch,et al.  Synthesis and in vitro characterization of fluorinated U-50488 analogs for PET studies of kappa opioid receptors. , 1990, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[14]  M. Sbacchi,et al.  (1S)-1-(aminomethyl)-2-(arylacetyl)-1,2,3,4-tetrahydroisoquinoline and heterocycle-condensed tetrahydropyridine derivatives: members of a novel class of very potent kappa opioid analgesics. , 1991, Journal of medicinal chemistry.

[15]  M. Kuhar,et al.  In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors. , 1987, Life sciences.

[16]  A. Wilson,et al.  An improved synthesis of (3-N-[11C]methyl)spiperone. , 1986, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[17]  Jonathan M. Links,et al.  Imaging dopamine receptors in the human brain by positron tomography , 1983 .

[18]  H. Mazarguil,et al.  [125I][D-Ala2]deltorphin-I: A high affinity, delta-selective opioid receptor ligand , 1991, Peptides.

[19]  J. Zajac,et al.  Binding in vivo of selective μ and δ opioid agonists: Localization by autoradiography , 1993, Neuropeptides.

[20]  G. De Sarro,et al.  Anticonvulsant effects of U-54494A and U-50488H in genetically epilepsy-prone rats and DBA/2 mice: a possible involvement of glycine/NMDA receptor complex. , 1993, General pharmacology.

[21]  F. Tortella,et al.  Kappa opioids: therapeutic considerations in epilepsy and CNS injury. , 1994, Clinical neuropharmacology.

[22]  Alan A. Wilson,et al.  Synthesis of a Radiotracer for Studying k‐Subtype Opiate Receptors: N‐[11C‐methyl]‐N‐(trans‐2‐pyrrolidinyl‐cyclohexyl)‐3,4‐dichlorophenylacetamide ([11C](±)U‐50488H) , 1992 .

[23]  H N Wagner,et al.  Radiosynthesis of an opiate receptor binding radiotracer: [11C]carfentanil. , 1985, The International journal of applied radiation and isotopes.

[24]  R. Vink,et al.  kappa-Opioid antagonist improves cellular bioenergetics and recovery after traumatic brain injury. , 1991, The American journal of physiology.

[25]  D. Scopes,et al.  A potent new class of kappa-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines. , 1993, Journal of medicinal chemistry.